Isatin (1H indole 2, 3-dione) is a heterocyclic, endogenous lead molecule recognized in humans and different plants. The isatin nucleus and its derivatives are owed the attention of researchers due to their diverse pharmacological activities such as anticancer, anti-TB, antifungal, antimicrobial, antioxidant, anti-inflammatory, anticonvulsant, anti-HIV, and so on. Many research chemists take advantage of the gentle structure of isatins, such as NH at position 1 and carbonyl functions at positions 2 and 3, for designing biologically active analogues via different approaches. Literature surveys based on reported preclinical, clinical, and patented details confirm the multitarget profile of isatin analogues and thus their importance in the field of medicinal chemistry as a potent chemotherapeutic agent. This review represents the recent development of isatin analogues possessing potential pharmacological action in the years 2016–2020. The structure–activity relationship is also discussed to provide a pharmacophoric pattern that may contribute in the future to the design and synthesis of potent and less toxic therapeutics.
1 September 2015 in Bioorganic & Medicinal Chemistry
A new high performance thin layer chromatography method was established for the determination of aripiprazole in bulk and tablet formulation. The estimation of aripiprazole was performed on thin layered aluminum backed plates coated with 200 μm layer of silica gel 60 F254 (10 cm × 10 cm) using mobile phase carbon tetrachloride: methanol: triethyl amine (2.5:2.4:0.1 v/v/v). Densitometric detection of aripiprazole was performed at 255 nm. Aripiprazole show linear relationship over the desired concentration range 300-1800 ng with correlation coefficient is 0.998. The R value for aripiprazole was found to be 0.58 ± 0.02. The established method was employed for tablet formulation and percent label claim for aripiprazole was found to be in the range 98-100 % and the % amount found in range from tablet formulation show that there is no interference from excipients available in tablet formulation. As per international conference on harmonization the established method was successfully validated to various parameter like linearity, precision, accuracy, ruggedness, robustness, detection limit and quantitation limit and showed satisfactory results for all parameters hence it is proved that the established method is simple, accurate, linear, precise, rugged, robust, sensitive and economical in nature. This method can be utilized for the routine quality control analysis of aripiprazole in bulk and tablet formulation.
A stability-indicating high-performance thin-layer chromatography method for determination of benazepril both in bulk and pharmaceutical formulation has been developed and validated as per ICH guidelines. The benazepril was analyzed on pre-coated silica gel GF254 plates using Carbon tetrachloride: Methanol: Triethylamine (7.6: 2.4: 0.1 v/v) as the mobile phase. The concentration of benazepril was determined by densitometry at 240 nm. The method was found to be linear, with r2 = 0.998±0.3347 in the concentration range 200 - 1200 ng per spot. The LOD and LOQ were 19.48 ng and 59.03 ng per spot respectively. Benazepril was subjected to forced degradation like acid and alkali hydrolysis, oxidation, photo and thermal degradation. The drug was found to degrade under acidic, basic, oxidative and thermal conditions. The degraded product was well resolved from the pure drug with significantly different Rf value. In validation, it was found that the method is repeatable, selective and accurate for the estimation of benazepril. The proposed developed stability-indicating HPTLC method can be applied for identification and quantitative determination of benazepril in bulk drug and pharmaceutical formulation.